Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/03/2011 | US20110024493 System for providing anonymous competition entry |
02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
02/02/2011 | EP2280076A1 Method for expressing homologous proteins and/or peptides in dothideomycetes fungi |
02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
02/02/2011 | EP2280068A1 Novel aldolase and production process of substituted alpha-keto acids |
02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
02/02/2011 | EP2280063A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (RIP) saporin and saporin fusion chimaeras |
02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
02/02/2011 | EP2279248A2 Proteins |
02/02/2011 | EP2279002A2 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same |
02/02/2011 | EP1013763B1 Canine interleukin 18 production method |
02/02/2011 | CN1683551B cow fetus agent prepared by composite enzyme method |
02/02/2011 | CN101965409A Recombinant factor viii having increased stability |
02/02/2011 | CN101965406A Antibody targeting through a modular recognition domain |
02/02/2011 | CN101965403A Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
02/02/2011 | CN101965363A Hybrid immunoglobulins with moving parts |
02/02/2011 | CN101962666A Method for preparing chitin, L-calcium lactate and compound amino acid or peptide from carapace waste |
02/02/2011 | CN101962652A Complex of human glucagon-like peptide (GLP)-1 and preparation method thereof |
02/02/2011 | CN101962647A Biosynthesis gene cluster of Nocathiacins and application thereof |
02/02/2011 | CN101962596A Method for synchronously preparing walnut oil and walnut peptide |
02/02/2011 | CN101962413A Fusion protein with transdermal capability and interleukin-10 activity as well as coding gene and application thereof |
02/02/2011 | CN101962411A Dengue virus serology early diagnosis reagent |
02/02/2011 | CN101962401A Polypeptin and preparation and application thereof |
02/02/2011 | CN101591635B Recombinant streptomyces ansochromogenes, preparation method thereof and use thereof |
02/02/2011 | CN101591634B Method for producing nikkomycin Z, special culture medium of nikkomycin Z and special engineering bacteria of nikkomycin Z |
02/02/2011 | CN101531967B Method for producing alpha interferon and dedicated bacteria therefor |
02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
02/01/2011 | US7879988 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
02/01/2011 | US7879591 Vector comprising lysophosphatidic acid acyltransferase sequences for use in generating yeast with enhanced capacity to produce long-chain polyunsaturated fatty acids |
02/01/2011 | US7879590 Transformed yeast for use tools in monitoring effector binding activities associated with mitogen activated protein kinases; identifying genic modulators |
02/01/2011 | US7879586 Gene encoding methylated catechin synthase |
02/01/2011 | US7879582 Method for the recombination of genetic elements |
02/01/2011 | US7879578 Self-assembled proteins and related methods and protein structures |
02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
02/01/2011 | US7879557 Isolated fluorescent protein from Clytia gregaria CGFP and use thereof |
02/01/2011 | US7879330 Monoclonal antibody for use in passive immunization against botulinum intoxication; immunotherapy |
02/01/2011 | US7879328 Antibodies that immunospecifically bind to B lymphocyte stimulator |
02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
02/01/2011 | US7879111 System and method for RFID transfer of MAC, keys |
02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
02/01/2011 | CA2319084C Novel collectin |
02/01/2011 | CA2274806C H mutant alpha-amylase enzymes |
02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
02/01/2011 | CA2188432C Melanoma antigens |
02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
02/01/2011 | CA1341610C Osteogenic polypeptides |
01/27/2011 | WO2011011674A2 Production of erythropoiesis stimulating protein using metal ions |
01/27/2011 | WO2011011464A2 Constructs and methods for efficient transformation of micro-organisms for production of carbon-based products of interest |
01/27/2011 | WO2011010792A2 Novel strain of paenibacillus sp. hpl-002 for producing alkaline xylanase, novel xylanase enzyme isolated therefrom, and method for producing same |
01/27/2011 | WO2011009416A1 Biosynthetic gene cluster of nocathiacins and use thereof |
01/27/2011 | WO2010088276A3 Polynucleotide aptamer-based cross -linked materials and uses thereof |
01/27/2011 | US20110023184 Axmi-205 pesticidal gene and methods for its use |
01/27/2011 | US20110023138 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
01/27/2011 | US20110021758 Hybrid antibodies |
01/27/2011 | US20110021757 Transgenic silkworm capable of producing antibody and method for production thereof |
01/27/2011 | US20110021753 Method for Preparing Porous Collagen Matrices |
01/27/2011 | US20110021752 Tropoelastin Derivatives |
01/27/2011 | US20110021751 Plasmid Vector |
01/27/2011 | US20110021611 Efficient cell culture system for hepatitis c virus genotype 5a |
01/27/2011 | US20110021445 Compositions and methods for treating erectile dysfunction |
01/27/2011 | US20110021444 Compositions for controlling hair growth |
01/27/2011 | US20110021442 Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
01/27/2011 | US20110021430 Modified vitamin k-dependent polypeptides |
01/27/2011 | US20110020951 Purified sr-p70 protein |
01/27/2011 | US20110020898 Thermostable Nucleic Acid Polymerase From Thermococcus Gorgonarius |
01/27/2011 | US20110020872 Microorganism producing cyclic compound |
01/27/2011 | US20110020871 Process for the Preparation of Insulin Conjugates |
01/27/2011 | US20110020870 Methods for producing modified glycoproteins |
01/27/2011 | US20110020869 Methods for altering acetic acid production and enhancing cell death in bacteria |
01/27/2011 | US20110020868 Bacterial leader sequences for increased expression |
01/27/2011 | US20110020867 Constructs And Methods For Efficient Transformation Of Micro-Organisms For Production Of Carbon-Based Products Of Interest |
01/27/2011 | US20110020866 Promoter sequence for the expression of recombinant proteins in Lactococcus lactis |
01/27/2011 | US20110020865 Gene Expression Technique |
01/27/2011 | US20110020864 Preparation of High Purity Collagen |
01/27/2011 | US20110020853 Compositions and methods for detecting phosphomonoester |
01/27/2011 | US20110020811 involving overexpression of alpha 1,2 mannosidase (MAN1C1) activity to improve protein production; improved glycoprotein production |
01/27/2011 | US20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
01/27/2011 | US20110020784 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
01/27/2011 | US20110020394 Pcv2 orf2 virus like particle with foreign amino acid insertion |
01/27/2011 | US20110020387 Malaria vaccine |
01/27/2011 | US20110020382 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics |
01/27/2011 | US20110020372 Follistatin domain containing proteins |
01/27/2011 | US20110020369 Engineered anti-tslpr antibodies |
01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
01/27/2011 | US20110020347 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
01/27/2011 | US20110020346 Anti-vegf antibodies |
01/27/2011 | US20110020345 Drug fusions and conjugates |
01/27/2011 | US20110020342 Igf-1 fusion polypeptides and therapeutic uses thereof |
01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
01/27/2011 | US20110020323 Gram-positive bacteria specific binding compounds |